News
Investing.com -- INmune Bio Inc. (NASDAQ: INMB) stock fell 60% in pre-market trading Monday after the company reported mixed results from its Phase 2 MINDFuL trial of XPro in early Alzheimer’s disease ...
Investing.com -- Unicycive Therapeutics Inc (NASDAQ:UNCY) stock fell 26% after the company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration for its Oxylanthanum ...
Investing.com -- Private equity firm Advent International has agreed to acquire a majority stake in LayerZero Power Systems, a manufacturer of power infrastructure equipment for data centers.
Investing.com - Shares in First Solar (NASDAQ:FSLR) gained in premarket U.S. trading on Monday, as analysts suggested that the solar-panel manufacturer may have been one of only renewable-energy ...
“President Trump has succeeded in making Fed Chairman Jerome Powell a ‘lame duck,’” wrote Louis Navellier of Navellier & ...
Investing.com -- The U.S. Supreme Court upheld a provision of the Affordable Care Act requiring insurers to cover preventive services, such as HIV prevention and cancer screenings, at no additional ...
Investing.com -- U.K. antitrust regulators have launched a formal investigation into Boeing (NYSE: BA)’s planned $4.7 billion acquisition of Spirit AeroSystems, potentially delaying or derailing the ...
Smallcap stock jumps 4% after signing agreement to acquire majority stake in Power-One Micro Systems
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
The shares of this PCB manufacturer are in focus after the company secured an order worth Rs 98 crore from a US firm. In this article, we will discuss more about this in detail. With a market ...
Investing.com -- BlackRock (NYSE: BLK) warned on Monday that the growing U.S. government debt might reduce investor interest ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
The FDA published a report highlighting a "severe worsening of chronic inflammatory demyelinating polyradiculoneuropathy" as a potential signal of serious risk with Vyvgart Hytrulo (efgartigimod alfa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback